ClinicalTrials.Veeva

Menu

Comparison of Multiple Oxygenation Targets With Different Oximeters in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Patients- Impact on Oxygen Flows

L

Laval University

Status

Not yet enrolling

Conditions

Respiratory Disease
Pneumonia
Hypoxemia
COPD Exacerbation

Treatments

Device: Nellcor oximeter
Device: Nonin oximeter
Device: Masimo oximeter

Study type

Interventional

Funder types

Other

Identifiers

NCT05819164
2023-4002

Details and patient eligibility

About

The oximeter is an instrument for monitoring patients receiving oxygen therapy. It displays pulse oxygen saturation (SpO2), which is a reflection of arterial oxygen saturation (SaO2). An accurate SpO2 value is essential for optimal management of the O2 flow delivered to patients. Several factors can influence this measurement and the choice of ventilatory support: the type of oximeter used, skin pigmentation and the oxygenation goal.

The objective of our study is to evaluate the impact of the oxygenation goal and the oximeter used on oxygen flows in patients with COPD (or with hypercapnia, or at risk of hypercapnia) and in patients without COPD (in particular pneumonia, pulmonary fibrosis and other pathologies) Our hypothesis is that the SpO2 target and oximeter used will have an impact on oxygen flows and that these effects will be synergistic in these different populations.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥ 18 years old
  • On conventional oxygen therapy with SpO2 between 88 and 100% with the usual oximeter and nasal cannula.
  • SpO2 < 92% in ambient air with the usual oximeter

Exclusion criteria

  • No availability of the SpO2 signal with the usual oximeter
  • False nails or nail polish
  • Severe anemia documented on the last blood count during the current hospitalization (Hb < 80g/L)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

40 participants in 5 patient groups

88% SpO2 target
Experimental group
Description:
During this periods , oxygen will be administered in manual titration to reach 88% of SpO2.
Treatment:
Device: Nellcor oximeter
Device: Masimo oximeter
Device: Nonin oximeter
90% SpO2 target
Experimental group
Description:
During this periods , oxygen will be administered in manual titration to reach 90% of SpO2.
Treatment:
Device: Nellcor oximeter
Device: Masimo oximeter
Device: Nonin oximeter
92% SpO2 target
Experimental group
Description:
During this periods , oxygen will be administered in manual titration to reach 92% of SpO2.
Treatment:
Device: Nellcor oximeter
Device: Masimo oximeter
Device: Nonin oximeter
94% SpO2 target
Experimental group
Description:
During this periods , oxygen will be administered in manual titration to reach 94% of SpO2.
Treatment:
Device: Nellcor oximeter
Device: Masimo oximeter
Device: Nonin oximeter
96% SpO2 target
Experimental group
Description:
During this periods , oxygen will be administered in manual titration to reach 96% of SpO2.
Treatment:
Device: Nellcor oximeter
Device: Masimo oximeter
Device: Nonin oximeter

Trial contacts and locations

0

Loading...

Central trial contact

ierre Alexandre Bouchard; Francois Lellouche

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems